Effects of chemerin/CMKLR1 in obesity-induced hypertension and potential mechanism.

BACKGROUND Obesity-induced hypertension (OIH) has a high morbidity and mortality, and its prevention and treatment has been a major challenge in clinical practice. Chemerin is a newly discovered adipokine closely related to OIH. METHODS Male Wistar rats (8W) were divided into either a high-fat diet or a regular diet group. Body weight and blood pressure were measured every two weeks. After 20 weeks, serum, adipose tissue and aortic arteries were collected. Arterial tensions were detected; Immunohistochemistry, ELISA and Western blotting were used to detect the expression of chemerin, CMKLR1, Rock2 and P-MYPT1 in the aorta and perivascular adipose tissues. RESULTS After 4 weeks, the body weight, systolic blood pressure, diastolic blood pressure and mean arterial pressure were all significantly higher in the high-fat diet group (P<0.05). There was no significant difference in serum chemerin concentration between the OIH group and the control group. However, chemerin and CMKLR1 protein expression was higher in aortic arteries and perivascular adipose tissues of the OIH group (P<0.05). The arterial tension induced by chemerin 9 (1 μM) and the expression of Rock2 and P-MYPT1 were higher in the OIH group (P<0.05). CONCLUSION OIH positively correlated with chemerin in tissues but not serum. Arterial tension was increased by chemerin 9. Rock2/P-MYPT1 might be involved in the pathogenesis of increased vascular tone in OIH rats.

[1]  G. Aksan,et al.  Chemerin as an independent predictor of cardiovascular event risk , 2016, Therapeutic advances in endocrinology and metabolism.

[2]  R. Mattes,et al.  Higher plasma lipopolysaccharide concentrations are associated with less favorable phenotype in overweight/obese men , 2015, European Journal of Nutrition.

[3]  S. Watts,et al.  Chemerin: A comprehensive review elucidating the need for cardiovascular research. , 2015, Pharmacological research.

[4]  R. Touyz,et al.  Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox , 2015, Hypertension.

[5]  E. Reisin,et al.  Treatment: special conditions. Metabolic syndrome: obesity and the hypertension connection. , 2015, Journal of the American Society of Hypertension : JASH.

[6]  K. Neves,et al.  Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity? , 2014, Clinical science.

[7]  A. Dorrance,et al.  Chemerin Connects Fat to Arterial Contraction , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Z. Fortes,et al.  The adipokine chemerin augments vascular reactivity to contractile stimuli via activation of the MEK-ERK1/2 pathway. , 2012, Life sciences.

[9]  Geoffrey A Head,et al.  Developmental origins of obesity‐related hypertension , 2012, Clinical and experimental pharmacology & physiology.

[10]  K. Ahn,et al.  Chemerin and Adiponectin Contribute Reciprocally to Metabolic Syndrome , 2012, PloS one.

[11]  Weiqing Wang,et al.  The association of serum chemerin level with risk of coronary artery disease in Chinese adults , 2012, Endocrine.

[12]  W. Spiering,et al.  Mechanisms linking obesity to hypertension , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[13]  T. Kotchen Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. , 2010, American journal of hypertension.

[14]  A. Saremi,et al.  Twelve-Week Aerobic Training Decreases Chemerin Level and Improves Cardiometabolic Risk Factors in Overweight and Obese Men , 2010, Asian journal of sports medicine.

[15]  D. Goff,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[16]  P. Zimmet,et al.  Chemerin is a novel adipokine associated with obesity and metabolic syndrome. , 2007, Endocrinology.

[17]  E. Butcher,et al.  Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism* , 2007, Journal of Biological Chemistry.

[18]  A. Somlyo,et al.  Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. , 2003, Physiological reviews.

[19]  R. Paul,et al.  Distinct Pathways of Ca 2+ Sensitization in Porcine Coronary Artery: Effects of Rho-Related Kinase and Protein Kinase C Inhibition on Force and Intracellular Ca 2+ , 2001, Circulation research.

[20]  P. Gallagher,et al.  Rho-kinase-mediated Ca2+-independent contraction in rat embryo fibroblasts. , 2004, American journal of physiology. Cell physiology.